-
Caballeta Bio Shares Surge The Most In 23 Months In A Single Day As It Unveils Plan To Meet FDA By 2025 For Systemic Sclerosis Drug Trial
Thursday, November 28, 2024 - 1:59am | 374Read More...Shares of Caballeta Bio Inc (NASDAQ:CABA) rose by 24.38% to $3.01 apiece on Wednesday and advanced by 4.65% to $3.15 per share in after-hours trading, following an update on their Systemic Sclerosis drug trial. Also read: Trump’s Tariff Threat To Canada May Disrupt Oil Markets, Inflate...
